Stereotaxis to Report First Quarter 2026 Financial Results on May 12, 2026

Stereotaxis (NYSE: STXS) will report its first quarter 2026 financial results after U.S. market close on Tuesday, May 12, 2026.

Rhea-AI Summary

Stereotaxis (NYSE: STXS) will report its first quarter 2026 financial results after U.S. market close on Tuesday, May 12, 2026. The company will host a live conference call and webcast at 4:30 p.m. ET to discuss results and corporate developments.

Dial-in numbers and a live/replay webcast will be available via the company’s investor relations website; a phone replay will be accessible for one month beginning about four hours after the call.

Argus Apr 21 session

-3.03% close to close Open Argus

Details

News Market Reaction – STXS

On Apr 21, the day this news came out, STXS closed 3.03% below the previous close.

Data tracked by StockTitan Argus for the Apr 21 session.

Key Figures

Earnings call time (ET): 4:30 p.m. ET Earnings call time (PT): 1:30 p.m. PT US/Canada dial-in: 800-715-9871 +4 more

Earnings call time (ET)

4:30 p.m. ET

First quarter 2026 results call on May 12, 2026

Earnings call time (PT)

1:30 p.m. PT

First quarter 2026 results call on May 12, 2026

US/Canada dial-in

800-715-9871

Access number for live conference call

International dial-in

1-646-307-1963

Access number for live conference call

Participant pass code

6082771

Code required to join first quarter 2026 call

Replay availability

1 month

Phone replay period after the conference call

Patients treated

over 150,000 patients

Cumulative global procedures using Stereotaxis technology

Previous Earnings date Reports

1 past event · Latest: Feb 12

Same Type 1 event

1. Feb 12

   Earnings date announcement

   24h Move

   -0.5%

   Set reporting date and call details for Q4 and full-year 2025 results.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

surgical robotics, minimally invasive endovascular intervention

2 terms

surgical robotics medical

"Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention"

Surgical robotics are computer-guided machines—robotic arms, cameras and software—that assist surgeons by increasing steadiness, precision and access during operations, acting like a highly controlled extension of a surgeon’s hands. Investors pay attention because these systems can reshape hospital spending, create recurring revenue from instruments, software and service contracts, and their commercial success depends on clinical outcomes, regulatory approval and how quickly hospitals adopt the technology.

minimally invasive endovascular intervention medical

"global leader in surgical robotics for minimally invasive endovascular intervention"

A minimally invasive endovascular intervention is a medical procedure that treats blood vessel problems from inside the vessel using thin tubes, wires and small tools threaded through a tiny puncture instead of large surgical cuts; think of fixing plumbing by inserting tools through the pipes rather than tearing out walls. It matters to investors because these procedures typically cut hospital stays, lower complication rates and can expand patient access, which affects device sales, procedure volumes and healthcare costs.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ST. LOUIS, April 21, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2026 first quarter on Tuesday, May 12, 2026 at the close of the U.S. financial markets. The Company will host a conference call and webcast at 4:30 p.m. EST that day to discuss the Company’s results and corporate developments.

What:		Stereotaxis first quarter 2026 financial results conference call
When:		Tuesday, May 12, 2026, at 4:30 p.m. ET (1:30 p.m. PT)
Dial In Number:		To access the live call, dial 800-715-9871 (US and Canada) or 1-646-307-1963 (International) and give the participant pass code 6082771.
Webcast:		To access the live and replay webcast, please visit the investor relations section of Stereotaxis’ website at http://ir.stereotaxis.com/.
Call Replay:		A phone replay of the call will be available for one month beginning approximately four hours following the end of the call. To request access for a replay of the conference call, please click here.

About Stereotaxis
Stereotaxis (NYSE: STXS) is a pioneer and global leader in innovative surgical robotics for minimally invasive endovascular intervention. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, expand access to minimally invasive therapy, and enhance the productivity, connectivity, and intelligence in the operating room. Stereotaxis technology has been used to treat over 150,000 patients across the United States, Europe, Asia, and elsewhere. For more information, please visit www.stereotaxis.com.

Investor Contacts:                                        
David L. Fischel                                        
Chairman and Chief Executive Officer                        
                                                        
Kimberly Peery                                                
Chief Financial Officer

314-678-6100
Investors@Stereotaxis.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Stereotaxis (STXS) report first quarter 2026 results and hold the earnings call?

Stereotaxis will report Q1 2026 results after market close on May 12, 2026, with a call at 4:30 p.m. ET. According to the company, the call and webcast will review the quarter’s financial results and corporate developments following the market close.

How can investors join the Stereotaxis (STXS) May 12, 2026 conference call and webcast?

Investors can dial 800-715-9871 (US/Canada) or 1-646-307-1963 with pass code 6082771 to join the live call. According to the company, the live and replay webcast will be available on Stereotaxis’ investor relations website.

Will Stereotaxis (STXS) provide a replay of the May 12, 2026 earnings call and for how long?

Yes. A phone replay will be available for one month beginning about four hours after the call ends. According to the company, webcast replays will also be accessible via the investor relations section of its website.

What time is the Stereotaxis (STXS) conference call for investors in Pacific Time on May 12, 2026?

The conference call is scheduled for 1:30 p.m. PT on May 12, 2026. According to the company, the call occurs at 4:30 p.m. ET, which corresponds to 1:30 p.m. PT, immediately following the market close.

What topics will Stereotaxis (STXS) cover during the May 12, 2026 Q1 earnings call?

The company will discuss its first quarter 2026 financial results and corporate developments. According to the company, management intends to review quarterly performance and provide commentary on recent operational and strategic updates during the webcast.